Login / Signup

Glucagon-like peptide-1 therapy in people with obesity restores natural killer cell metabolism and effector function.

Conor De BarraMohammed KhalilArimin MatCliona O'DonnellFerrah ShaamileKiva BrennanDonal O'SheaAndrew E Hogan
Published in: Obesity (Silver Spring, Md.) (2023)
The restoration, by GLP-1 therapy, of NK cell functionality in PWO may be contributing to the overall benefits being seen with this class of medication.
Keyphrases
  • nk cells
  • weight loss
  • metabolic syndrome
  • single cell
  • cell therapy
  • healthcare
  • insulin resistance
  • emergency department
  • dendritic cells
  • immune response
  • weight gain
  • mesenchymal stem cells
  • type iii